コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ues mainly reflect the low frequency of true penicillin allergy.
2 ephalosporin use in patients with a recorded penicillin allergy.
3 m to have a DA, and the most common label is penicillin allergy.
4 of patients with an unsubstantiated label of penicillin allergy.
5 plex (MHC) I gene HLA-B in the occurrence of penicillin allergy.
6 be very safe in patients with no history of penicillin allergy.
7 porin antibiotics among inpatients reporting penicillin allergy.
8 testing is safe and effective in ruling out penicillin allergy.
9 used, even in individuals with a history of penicillin allergy.
10 tandings about the characteristics of a true penicillin allergy.
11 rting 2315 antibiotic allergies, 1225 with a penicillin allergy.
12 was used (600 mg per dose) for patients with penicillin allergy.
13 allergy assessment following self-report of penicillin allergy.
14 of-care risk assessment for adults reporting penicillin allergies.
15 ck sufficient resources to address inpatient penicillin allergies.
16 areness on the implications of self-reported penicillin allergies.
17 %; I2 = 54.3%) than for those with confirmed penicillin allergy (3.0%; 95% CrI, 0.01%-17.0%; I2 = 88.
18 at the site) were used among patients with a penicillin allergy; after removal of the alert, administ
19 of cephalosporin use before and after an EHR penicillin allergy alert was removed in 1 of the study r
20 icillin may allow clinicians to exclude true penicillin allergy, allowing these patients to receive p
22 study examines a clinical decision model for penicillin allergies among pediatric patients; the model
23 paring clinical history to the skin test for penicillin allergy among patients with and without a pos
24 vancomycin prophylaxis for those with severe penicillin allergies and antibiotic-resistant organisms.
25 clude identification of HLA associations for penicillin allergy and a microRNA biomarker/mechanism fo
26 ded for use only in patients with a label of penicillin allergy and does not apply to other beta-lact
27 ed studies conducted in patients reporting a penicillin allergy and in whom skin tests and/or specifi
32 ed as penicillin allergic, most diagnoses of penicillin allergy are made in childhood and relate to e
34 0% to 20% of patients reporting a history of penicillin allergy are truly allergic when assessed by s
36 not detail the epidemiology or aetiology of penicillin allergy, as this is covered extensively in th
38 pital emergency department, a pharmacist-led penicillin allergy assessment via medical records review
39 cribing of cephalosporins to patients with a penicillin allergy at 1 of the 2 sites, 58 228 courses o
40 ation or dispensing among patients without a penicillin allergy at the same site and patients at the
41 osporin use among patients with or without a penicillin allergy at the site that removed the warning
45 algorithm to define which patients reporting penicillin allergy can be safely treated at STI clinics
46 y transmitted infection (STI) clinics report penicillin allergies, complicating treatment for syphili
47 approach, 67% of participants with reported penicillin allergy could safely receive first-line treat
51 lations, we developed and validated a simple penicillin allergy de-labeling prevalence measure from e
53 cient model for a non-allergy-specialist-led penicillin allergy de-labelling (PADL) service has not b
56 rgy or immunology, but who wish to develop a penicillin allergy de-labelling service for their patien
57 in challenges might support the expansion of penicillin allergy delabeling efforts, the perceived ris
59 out proceeding formal skin testing to tackle penicillin allergy efficiently within complex healthcare
60 At the same time, there is great promise for penicillin allergy evaluation and de-labeling as an indi
61 t challenges are safe for incorporation into penicillin allergy evaluation efforts across age groups
62 estionnaire can safely identify patients for penicillin allergy evaluation in STI clinics by PST or G
65 [CI], 1.5-2.5), while absence of history of penicillin allergy had a negative likelihood ratio of 0.
67 amycin, which is often used in patients with penicillin allergy, had the highest rate of fatal (2.9/m
69 e findings suggest that most patients with a penicillin allergy history may safely receive cefazolin.
74 uated internal medicine inpatients reporting penicillin allergy in 3 periods: (1) standard of care (S
75 The exception is patients with confirmed penicillin allergy in whom additional care is warranted.
80 -based narrative review of the literature of penicillin allergy label carriage, the adverse effects o
87 impact of 2 strategies for a patient with a penicillin allergy label: (1) perform diagnostic testing
89 s penicillin allergic, but the prevalence of penicillin allergy labeling ranged from 0.9% to 10.2% ac
90 cohort study of more than 330 000 children, penicillin allergy labeling was common and varied widely
91 the fidelity of and outcomes associated with penicillin allergy-labeling in children is warranted.
98 tiatives to reduce the burden and impacts of penicillin allergy labels on antibiotic prescribing.
99 lergy label carriage, the adverse effects of penicillin allergy labels, and current approaches and ba
102 ll-appreciated that patients with documented penicillin allergies often receive broader-spectrum anti
103 ing 1) a medical error (failure to check for penicillin allergy or inadequate monitoring of antiepile
104 med and Medline, search terms used included "penicillin allergy" or "penicillin hypersensitivity" alo
105 erminants, provide an explicit definition of penicillin allergy, or list the specific criteria necess
106 oximately 90-99% of patients with a label of penicillin allergy (PenA) are not allergic when comprehe
107 ents with and without a positive history for penicillin allergy, positive and negative likelihood rat
108 a prospective, multicenter cohort inpatient penicillin allergy program, we identify the key targets
111 ntified in 44 participants with a history of penicillin allergy, resulting in a dual allergy meta-ana
114 as suggested various models of incorporating penicillin allergy screening and testing by different he
115 r patients solely with a family history of a penicillin allergy, symptoms of pruritus without rash, o
116 tic review was to identify whether inpatient penicillin allergy testing affected clinical outcomes du
122 rgies through a detailed allergy history and penicillin allergy testing should be a vital component o
127 spective was adopted, considering costs with penicillin allergy tests, and with hospital bed-days/out
131 es a strong case that the debunking of false penicillin allergies through a detailed allergy history
132 ble cases) unique hospitalized subjects with penicillin "allergy" to 2 unique discharge diagnosis cat
134 to avoid cephalosporin use in patients with penicillin allergies was associated with increased admin
137 cillin challenge in patients with a low-risk penicillin allergy was noninferior compared with standar
139 Patients 18 years of age with a low-risk penicillin allergy were offered a single-dose oral penic
141 how worse outcomes in patients with reported penicillin allergies who receive non-beta-lactam antibio
142 ved for studies of patients with unconfirmed penicillin allergy who had been exposed to perioperative
143 Patients with a concerning history of type I penicillin allergy who have a compelling need for a drug
144 study of 380 adult patients with a reported penicillin allergy who received antibiotics at a communi